Skip to main content

FDA Approves Long-Awaited Cholesterol Drugs

Federal regulators have signed off on a new drug that lowers cholesterol, a development that could bring an important but costly new medical tool to fighting heart disease.

Republish
Lead image for this article

Federal regulators have signed off on a new drug that lowers cholesterol, a development that could bring an important but costly new medical tool to fighting heart disease. The drugs — which could benefit millions — are an alternative to the much-cheaper statins, the common cholesterol-lowering drug that might not be adequate for some. (Wall Street Journal) 

Texans need truth. Help us report it.

Independent Texas reporting needs your support. The Texas Tribune delivers fact-based journalism for Texans, by Texans — and our community of members, the readers who donate, make our work possible. Help us bring you and millions of others in-depth news and information. Will you support our nonprofit newsroom with a donation of any amount?

Support independent Texas news

Become a member. Join today.

Choose an amount or learn more about membership.

$20 $25 $50 Other
Donate now

Information about the authors

Learn about The Texas Tribune’s policies, including our partnership with The Trust Project to increase transparency in news.

Explore related story topics